| Value | ₹450.0 Cr |
|---|
NSE filing, NSE: BALRAMCHIN. Summary written from the filing by ALFA Finder's alert engine.
Balrampur Chini Mills Ltd: key numbers
- Share price
- ₹673.00
- Market cap
- ₹14,243 Cr
- Revenue (annual)
- ₹6,271 Cr
- Net profit (annual)
- ₹378.5 Cr
- P/E (TTM)
- 38.4×Sector 27.9×
- Promoter holding
- 42.79%-0.07% QoQ
- FII holding
- 8.96%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Balrampur Chini Mills Ltd
All →Balrampur Chini Mills Dividend
Balrampur Chini Mills declared an interim dividend of Rs 4.00 per share for FY 2026-27. The record date is November 11, 2026, with payment by November 26, 2026.
Balrampur Chini Mills Results Update
Balrampur Chini Mills reported Q2 FY27 consolidated revenue of Rs 1,876.28 crore, up 12.3%, with EBITDA up 42.4%. The company also declared an interim dividend of Rs 4.00 per share.
Balrampur Chini Mills Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue Rs.1,876 Cr (+12.3%); standalone EBITDA margin 9.1% (vs 7.2%). Sugar PBIT up 166%; distillery margins compressed.
Balrampur Chini Mills Q2 FY27 Results: Net Profit ₹102.3 Cr, Up 89.8% YoY
Balrampur Chini Mills Ltd reported revenue from operations of ₹1,876 Cr (+12.3% YoY) and net profit of ₹102.3 Cr (+89.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹102.3 Cr · +89.8% YoY
Balrampur Chini Mills Board Meeting Date
Balrampur Chini Mills will hold a board meeting on 4 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The board will also consider an interim dividend for FY 2026-27.
Balrampur Chini Mills Employee Stock Options
Balrampur Chini Mills Limited has granted 1,21,268 Employee Stock Appreciation Rights (ESARs) under its 2023 ESAR plan, with an exercise price of ₹721.25 per unit.
Other other announcement announcements
All →Transchem Other Announcement
Transchem's monitoring agency reports no deviation in warrant proceeds utilisation for the quarter ended September 2026. No material facts were flagged.
Archidply Industries Other Announcement
Archidply Industries disclosed that its RTA, KFin Technologies, is shifting its corporate office to Kokapet, Hyderabad from December 1, 2026. The registered office is unchanged and shareholders should update correspondence addresses.
KEI Industries Other Announcement
Designated person Jashobant Singha Ray pledged 1,500 KEI Industries shares. After the transaction, 10,000 of his 18,000 shares are pledged, with no cash consideration disclosed.
Kansai Nerolac Paints Other Announcement
Kansai Nerolac authorised Pravin Chaudhari, Yash Ahuja and Rukmini Subramanian to determine material events from 1 December 2026. It only lists KMP and contact details.
Glenmark Pharmaceuticals Other Announcement
Glenmark's partner IGI will present updated Phase 1 clinical data for ISB 2001 (ABBV-2001) in relapsed/refractory multiple myeloma at the 68th ASH Annual Meeting. The presentation is scheduled for December 12, 2026.
Vineet Laboratories Other Announcement
Vineet Laboratories' board appointed SVRL & Co. as statutory auditors, subject to shareholder approval. The five-year term runs from the 10th AGM to the 16th AGM.